DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Cryptogenic organising pneumonia

Essential points for quick revision.

!
Escalate

Organising pneumonia can occasionally produce rapidly progressive hypoxaemic respiratory failure. Admit urgently when oxygenation, respiratory effort or haemodynamics are compromised, and investigate severe infection, pulmonary embolism, oedema, diffuse alveolar haemorrhage and acute eosinophilic pneumonia. Do not give outpatient corticosteroids for an undifferentiated acute bilateral infiltrative illness; obtain early respiratory and critical-care input and treat time-critical alternatives.

Synopsis

Recognise organising pneumonia as a clinicoradiological syndrome, exclude secondary causes and infection, and use specialist corticosteroid treatment with relapse-aware monitoring.

  • Organising pneumonia is a tissue-repair pattern with intra-alveolar granulation tissue; cryptogenic organising pneumonia is diagnosed only when no cause is found.
  • Secondary triggers include infection, connective-tissue disease, medicines, radiotherapy, malignancy, inflammatory bowel disease and transplantation.
  • Patients often have weeks of dry cough, breathlessness, fever, malaise and weight loss that fail to resolve with routine antibiotics.

Key red flags

Severe diffuse presentation

Rapidly spreading bilateral opacity, profound desaturation, tachypnoea or exhaustion can resemble ARDS and requires emergency respiratory and critical-care assessment.

Investigation priorities

01
Chest radiograph and HRCTFirst step

Define extent, distribution and features requiring another pathway.

Management branches

Diagnostic work-upMove beyond non-resolving pneumonia

Subacute multifocal consolidation persists despite appropriate initial antimicrobial care.

  1. Reassess physiological stability and obtain HRCT, looking for organising distribution while identifying pleural, nodal or mass-like features that require a cancer or infection pathway.
  2. Review all medicines, radiotherapy, systemic inflammatory symptoms, immune status and microbiology; do not use the word cryptogenic until secondary causes have been addressed.

Key medicines

PrednisoloneThere is no single current UK regimen for COP; specialist practice uses a daily induction tailored to physiological severity, followed by a slow response-guided taper over months under the local ILD protocol.
Long-term macrolide in selected casesNo routine COP dose should be copied across services; if an ILD specialist uses azithromycin or clarithromycin off label, follow the BTS macrolide and local antimicrobial protocol exactly.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom